Table 2.
Patient demographics and clinical characteristics.
| Jidabokuippo group | NSAIDs group | P value | |
|---|---|---|---|
| Age (years) | 60 (16–90) | 66 (23–90) | 0.2553 |
| Gender (male : female) | 35 : 46 | 37 : 44 | 0.8744 |
| The number of rib fractures (single : multiple) | 74 : 7 | 75 : 6 | >0.9999 |
| (bilateral, 2) | (bilateral, 0) | ||
| Site of rib fractures | Upper (1st–4th) 5 | Upper (1st–4th) 5 | 0.3620 |
| Middle (5th–8th) 34 | Middle (5th–8th) 43 | ||
| Lower (9th–12th) 46 | Lower (9th–12th) 37 | ||
| Injury severity score | 1 (1–10) | 1 (1–13) | 0.8050 |
| Chest AIS score | 1 (1–3) | 1 (1–3) | 0.7390 |
| Accompanying injuries | 4 | 6 | 0.7441 |
| Hemothorax 2 | |||
| Pneumohemothorax 1 | |||
| Whiplash injury 3 | Pneumothorax 1 | ||
| Kidney contusion 1 | Clavicular fracture 2 | ||
| Whiplash injury 1 | |||
| Comorbidities | 19 (23.5%) | 18 (22.2%) | >0.9999 |
ISS: injury severity score; AIS: abbreviated injury scale; NSAIDs: nonsteroidal anti-inflammatory drugs.